HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.

3rd Edition of International Conference on Gastroenterology

September 27-29, 2027 London, UK

September 27 -29, 2027 | London, UK

Cholangiocarcinoma

Cholangiocarcinoma

Cholangiocarcinoma is a type of cancer that arises from the cells of bile ducts. It is also known as bile duct cancer and is a rare cancer that can affect both the intrahepatic (within the liver) and extrahepatic (outside the liver) bile ducts. Bile ducts are involved in the production and transport of bile, a yellowish-green substance composed of bile salts, cholesterol, and other components that help the body digest fat. Cholangiocarcinoma can be classified as either primary or secondary. Primary cholangiocarcinoma originates from the bile ducts, while secondary cholangiocarcinoma is caused by cancer that has spread to the bile ducts from other parts of the body. The risk factors for cholangiocarcinoma include chronic biliary diseases such as primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC). Other risk factors include smoking, excessive alcohol intake, and certain genetic disorders. There may also be a link between cholangiocarcinoma and certain infections or toxins.

Committee Members
Speaker at GI Conferences - Alberto Maringhini

Alberto Maringhini

La Maddalena Hospital, Italy
Speaker at Gastroenterology Conference - Jose Luis Braga De Aquino

Jose Luis Braga De Aquino

Pontifical Catholic University of Campinas, Brazil
Speaker at Gastroenterology Conferences - Pubali Dhar

Pubali Dhar

University of Calcutta, India

Submit your abstract Today

Watsapp